Both from Science magazine's news section. The good, being that the annoying lawsuit against the NIH's funding decisions on stem cell research appears to be headed out the door. As far as I can tell, it's essentially been a couple of researchers who focus on adult stem cells packing a sad because now that researchers are also going to be allowed to focus on embryonic stem cells, there's going to be less money for their research. Bad form imho. The bad news is that gene patents might be back. Myriad genetics, the people who have delayed large amounts of work on breast cancer in the name of profit, appealed the ruling of a lower court that had found that genes were not patentable. There was some dissension in the ruling though, I haven't sorted it all out yet, fingers crossed it's not all bad.